Now, later or never? Challenges associated with hepatitis C treatment

Australian and New Zealand Journal of Public Health

Volumn 30, Issue 5, 2006, Pages 422-427

  McNally, Stephen ^a   Temple Smith, M ^a   Sievert, W ^b   Pitts, M K ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; PEGINTERFERON; RIBAVIRIN;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; AUSTRALIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH SURVEY; HEPATITIS C; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DECISION MAKING; FEMALE; HEALTH CARE SURVEYS; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; SEX FACTORS; VICTORIA;

EID: 33750318763     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2006.tb00457.x     Document Type: Article

References (16)

1. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2001. Sydney (AUST): University of New South Wales; 2002.
2. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2002. Sydney (AUST): University of New South Wales; 2003.
3. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2003. Sydney (AUST): University of New South Wales; 2004.
4. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2004. Sydney (AUST): University of New South Wales; 2005.
5. Batey R. Hepatitis C: where are we at and where are we going? Med J Aust. 2002;176:361-2.
6. Law M, Dore G, Bath N, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelac in Australia in 2001. Int J Epidemiol. 2003;32(5):717.
7. Department of Health and Ageing. National Hepatitis C Strategy 2005-2008. Canberra (AUST): Commonwealth of Australia; 2005.
8. Hepatitis C Virus Projections Working Group. Estimates and Projections of Hepatitis C Virus Epidemic in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2002.
9. McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1 infected patients with chronic hepatitis C. Gastroenterology. 2002;123:1061-9.
10. Gifford SM, O'Brien ML, Bammer G, et al. Australian women's experiences of living with hepatitis C virus: results from a cross-sectional survey. J Gastroenterol Hepatol. 2003;18(7):841-50.
11. Gifford SM, O'Brien ML, Bammer G, et al. Australian men's experiences of living with hepatitis C virus: results from a cross-sectional survey. J Gastroenterol Hepatol. 2005;20(1):79-86.
12. Musselman DL, Lawson DH, Gumnick JF, et al. Paroxetine for the Prevention of Depression induced by High-dose Interferon Alfa. N Engl J Med. 2001;344(12):961-6.
13. Kraus MR, Schäfer A, Faller H, et al. Paroxetine for the Treatment of Interferon-α-induced Depression in Chronic Hepatitis C. Aliment Pharmacol Ther. 2002;16:1091-9.
14. Mistler LA, Brunette MF, Marsh BJ, et al. Hepatitis C Treatment for People with Severe Mental Illness. Psychosomatics. 2006;47:2:93-107.
15. Thornton L, Barry J, Long J, et al. Comparison between self-reported hepatitis B, hepatitis C and HIV antibody status and oral fluid assay results in Irish prisoners. Commun Dis Public Health. 2000;3:4:253-5.
16. Shepard C, Finelli L, Alter M. Global epidemiology of hepatitis C virus infection. Lancet. 2005;September:558-67.